Frailty is associated with incident Alzheimer's disease and cognitive decline in the elderly

被引:313
|
作者
Buchman, Aron S.
Boyle, Patricia A.
Wilson, Robert S.
Tang, Yuxiao
Bennett, David A.
机构
[1] Rush Univ, Med Ctr, Rush Alzheimers Dis Ctr, Armour Acad Facil, Chicago, IL 60612 USA
[2] Rush Univ, Med Ctr, Dept Neurol, Chicago, IL 60612 USA
[3] Rush Univ, Med Ctr, Dept Behav Sci, Chicago, IL 60612 USA
[4] Rush Univ, Med Ctr, Rush Inst Healthy Aging, Chicago, IL 60612 USA
[5] Rush Univ, Med Ctr, Dept Internal Med, Chicago, IL 60612 USA
来源
PSYCHOSOMATIC MEDICINE | 2007年 / 69卷 / 05期
关键词
aging; frailty; cognitive decline; Alzheimer's disease; dementia;
D O I
10.1097/psy.0b013e318068de1d
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: To assess the association between frailty and incident Alzheimer's disease (AD) and cognitive decline. Frailty is common in older persons and associated with adverse health outcomes. Methods: Study subjects included 823 older persons without dementia who participated in the Rush Memory and Aging Project, a longitudinal study of aging, and underwent annual assessments of frailty, cognition, and diagnostic evaluation for AD. Results: During a 3-year follow-up, 89 of 823 participants developed AD. In a proportional hazards model, both baseline level of frailty and annual rate of change in frailty were associated with an increased risk of incident AD. Each additional one tenth of a unit increase on the frailty scale at baseline was associated with > 9% increased risk of AD (hazard ratio: 2.44; 95% confidence interval (CI): 1.49, 3.37); each one tenth of a unit increase in annual rate of change in frailty was associated with a 12% increased risk of AD (hazard ratio: 3.30; 95% CI: 1.52, 7.13). These results were unchanged in analyses controlling for vascular risk factors and vascular diseases. Results were similar with a categorical measure of frailty instead of a continuous measure. Further, linear mixed-effects models showed that the level of and rate of change in frailty were also associated with the rate of cognitive decline. Conclusion: Increasing frailty is associated with incident AD and the rate of cognitive decline in older persons. These findings suggest that frailty and AD may share similar etiologies.
引用
收藏
页码:483 / 489
页数:7
相关论文
共 50 条
  • [41] Progression of Alzheimer's disease and predictors of cognitive decline in Hong Kong Chinese elderly.
    Chung, PC
    Chu, L
    Chiu, P
    Luk, J
    Chan, F
    Hu, W
    Mok, W
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2004, 52 (04) : S42 - S42
  • [42] Predictors of cognitive and functional decline in Alzheimer's disease
    Mungas, D
    Reed, BR
    Jagust, WJ
    NEUROLOGY, 1999, 52 (06) : A436 - A437
  • [43] Cognitive decline in the prodromal phase of Alzheimer's disease
    Orgogozo, J. -M.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 : 24 - 24
  • [44] EARLY COGNITIVE DECLINE AND BIOMARKERS IN ALZHEIMER'S DISEASE
    Brusco, L., I
    PSYCHIATRY AND THE NEUROSCIENCES: INTERNATIONAL PERSPECTIVES, 2011, : 117 - 123
  • [45] Alzheimer's Disease: Exploring the Landscape of Cognitive Decline
    Tenchov, Rumiana
    Sasso, Janet M.
    Zhou, Qiongqiong Angela
    ACS CHEMICAL NEUROSCIENCE, 2024, 15 (21): : 3800 - 3827
  • [46] Apolipoprotein E and cognitive decline in Alzheimer's disease
    Plassman, BL
    Breitner, JCS
    NEUROLOGY, 1996, 47 (02) : 317 - 320
  • [48] Cognitive decline with preservation of creativity in Alzheimer's disease
    Miranda, D
    Apanasiewicz, N
    Fornazzari, LR
    NEUROBIOLOGY OF AGING, 2004, 25 : S116 - S116
  • [49] Homocysteine as a predictor of cognitive decline in Alzheimer's disease
    Oulhaj, Abderrahim
    Refsum, Helga
    Beaumont, Helen
    Williams, Jonathan
    King, Elizabeth
    Jacoby, Robin
    Smith, A. David
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2010, 25 (01) : 82 - 90
  • [50] Epigenetic regulation of cognitive decline in Alzheimer's disease
    Graff, J.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S26 - S26